检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]江苏大学附属武进医院神经外科,常州213002 [2]江苏大学附属武进医院中心实验室,常州213002
出 处:《江苏医药》2009年第11期1306-1308,共3页Jiangsu Medical Journal
基 金:常州市科技局社会发展基金资助项目(CS2007231)
摘 要:目的探讨重组人促红细胞生成素(rhEPO)对大鼠外伤性脑损伤的神经保护机制。方法将60只健康成年雄性SD大鼠随机分成5组:1000 U/kg、3000 U/kg、5000 U/kg rhEPO治疗(A、B、C)组、胞二磷胆碱治疗(D)组和生理盐水(E)组。采用改进的Feeney法制作大鼠自由落体脑创伤模型。伤后6 h、24 h、3 d、5 d、7 d断尾采血,运用双抗体夹心ELISA方法检测各组治疗后血清中S100B蛋白和白细胞介素6(IL-6)的含量。结果与E组相比较,B和C组血清中S100B蛋白含量显著降低(P<0.01),rhEPO各治疗组血清中IL-6的含量均显著降低(P<0.01)。S100B蛋白下降程度与rhEPO剂量成正比,中等剂量rhEPO能更好降低血清中IL-6的含量。结论rhEPO可能通过抑制脑外伤后S100B和IL-6的合成与分泌,降低全身和局部的炎症反应程度,从而发挥神经保护作用。Objective To explore the neuroprotective mechanisms of recombinant humam erythropoietin(rhEPO) on the rats after traumatic brain injury. Methods Sixty healthy adult male SD rats were randomly dividied into 3 rhEPO-treated groups of 1000 U/kg (A), 3000 U/kg(B)and 5000 U/kg, nicholin-treated group(D) and normal saline group(E) . The modified Feeneys traumatic brain injury model was made. Serum samples were collected at 6^th h, 24^th h, 3^rd, 5^th and 7^th d after trauma. The serum S100B protein and interleukirr6(IL-6) after treatment were detected with double antibody sandwich ELISA. Results compared with group E,the serum SI00B protein content was significantly lower in groups B and C (P〈0. 01), and the serum IL-6 content was also significantly lower in 3 rhEPO-treated groups (P〈0.01). The degree of decrease in serum S100B protein was positively correlated with the dosage of rhEPO. Medium dosage of rhEPO decreased the content of serum IL-6 more than the others. Conclusion Inhibition of the composition and secretion of S100B protein and IL-6 by EPO might be one of the mechanisms in decreasing inflammatory reaction systemically and locally and exerting a neuroprotective effect after traumatic brain injury.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249